159 related articles for article (PubMed ID: 33039988)
1. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).
Bracken L; McDonough E; Ashleigh S; Wilson F; Shakeshaft J; Ohia U; Mistry P; Jones H; Kanji N; Liu F; Peak M
BMJ Open; 2020 Oct; 10(10):e036508. PubMed ID: 33039988
[TBL] [Abstract][Full Text] [Related]
2. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
[TBL] [Abstract][Full Text] [Related]
3. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
Hofmanová JK; Mason J; Batchelor HK
Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
[TBL] [Abstract][Full Text] [Related]
4. A randomized cross-over study to evaluate the swallow-enhancing and taste-masking properties of a novel coating for oral tablets.
Uloza V; Uloziene I; Gradauskiene E
Pharm World Sci; 2010 Aug; 32(4):420-3. PubMed ID: 20524068
[TBL] [Abstract][Full Text] [Related]
5. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
[TBL] [Abstract][Full Text] [Related]
7. Single-dose pharmacokinetics of pediatric and adult formulations of etravirine and swallowability of the 200-mg tablet: results from three Phase 1 studies.
Kakuda TN; Berckmans C; De Smedt G; Leemans R; Leopold L; Peeters M; Nijs S; Vyncke V; van Solingen-Ristea R; Hoetelmans RM
Int J Clin Pharmacol Ther; 2013 Sep; 51(9):725-37. PubMed ID: 23924679
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
[TBL] [Abstract][Full Text] [Related]
9. In situ coating makes it easier for children to swallow and tolerate tablets and capsules.
El Edelbi R; Eksborg S; Lindemalm S
Acta Paediatr; 2015 Sep; 104(9):956-61. PubMed ID: 25982837
[TBL] [Abstract][Full Text] [Related]
10. Developing methodology to evaluate the oral sensory features of pharmaceutical tablet coatings.
Hofmanová JK; Rajabi-Siahboomi A; Haque S; Mason J; Teckoe J; To D; Batchelor HK
Int J Pharm; 2019 May; 562():212-217. PubMed ID: 30910634
[TBL] [Abstract][Full Text] [Related]
11. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
Liu F; Ghaffur A; Bains J; Hamdy S
Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
[TBL] [Abstract][Full Text] [Related]
13. Evidence of acceptability of oral paediatric medicines: a review.
Mistry P; Batchelor H;
J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
[TBL] [Abstract][Full Text] [Related]
14. Factor Analysis of Patients Who Find Tablets or Capsules Difficult to Swallow Due to Their Large Size: Using the Personal Health Record Infrastructure of Electronic Medication Notebooks.
Asano M; Imai S; Shimizu Y; Kizaki H; Ito Y; Tsuchiya M; Kuriyama R; Yoshida N; Shimada M; Sando T; Ishijima T; Hori S
J Med Internet Res; 2024 Apr; 26():e54645. PubMed ID: 38657229
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of developing children's Pill School within a UK hospital.
Rashed AN; Terry D; Fox A; Christiansen N; Tomlin S
Arch Dis Child; 2021 Jul; 106(7):705-708. PubMed ID: 33229414
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children.
Kekitiinwa A; Musiime V; Thomason MJ; Mirembe G; Lallemant M; Nakalanzi S; Baptiste D; Walker AS; Gibb DM; Judd A
Antivir Ther; 2016; 21(7):579-585. PubMed ID: 27128199
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of different oral formulations in infants and preschool children.
van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
[TBL] [Abstract][Full Text] [Related]
19. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
[TBL] [Abstract][Full Text] [Related]
20. How do tablet properties influence swallowing behaviours?
Yamamoto S; Taniguchi H; Hayashi H; Hori K; Tsujimura T; Nakamura Y; Sato H; Inoue M
J Pharm Pharmacol; 2014 Jan; 66(1):32-9. PubMed ID: 24128037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
